compounded information therapeutics, inc.

37 king street
chappauqua, new york 10514

NYS Entity Status
ACTIVE

NYS Filing Date
JUNE 13, 2013

NYS DOS ID#
4417302

County
WESTCHESTER

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2013 - COMPOUNDED INFORMATION THERAPEUTICS, INC.









Buffer

submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • NY AG presses TransUnion, Experian for cybersecurity details
    By DAVID KLEPPER, Associated Press - Tuesday Sep 19, 2017

    ALBANY, N.Y. (AP) — New York Attorney General Eric Schneiderman is pressing TransUnion and Experian to explain what cybersecurity they have in place to protect sensitive consumer information following a recent breach at Equifax that exposed the data of 143 million Americans.In letters to executives at the two credit monitoring companies, the Democratic attorney general asked them to describe their existing security systems as well as what changes they've made since the Equifax cyberattack."The unprecedented data breach experienced by Equifax Inc.

    Source: SFGATE.com: Tech News
  • FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
    By Ben Fidler - Tuesday Aug 29, 2017

    The heat is on Acorda Therapeutics once again. Months after Acorda lost a key group of patents, the FDA has declined to review, at least for now, an experimental Parkinson’s disease drug that is critical to the company’s future. Acorda (NASDAQ: ACOR) said this morning that the FDA has sent the Ardsley, NY, company a […]

    Source: Xconomy New York
  • Insurers Battle Families Over Costly Drug for Fatal Disease
    By KATIE THOMAS - Thursday Jun 22, 2017

    The case of Exondys 51 poses emotionally charged issues for families of young boys with a rare illness, who are fighting companies to get coverage for an expensive drug approved on a lower bar of proof.

    Source: NYT > Home Page
  • For Parkinson’s, Two New Drugs Coming As Prevail Gets Started in NY
    By Ben Fidler - Wednesday Aug 9, 2017

    A drug that actually slows or reverses the brain damage inflicted by Parkinson’s disease, rather than just alleviates its often debilitating symptoms, remains elusive. But Prevail Therapeutics, a startup just launched in New York, has become the latest to try. This morning, the Silverstein Foundation, a nonprofit organization formed by OrbiMed partner Jonathan Silverstein, announced […]

    Source: Xconomy New York
  • New Jersey Sues Insys Over Opioid Painkiller
    Thursday Oct 5, 2017

    New Jersey’s attorney general filed a lawsuit Thursday against drugmaker Insys Therapeutics Inc., claiming it fraudulently marketed a powerful painkiller for widespread use that was intended to treat serious cancer pain.

    Source: The Wall Street Journal: U.S. Business